Lenovo is not just making waves in the technology market, as its influence also stretches to research, allowing key industries to advance their genome sequencing. |
Photo from Lenovo |
A life saver?
Through its 4th generation of its Genomics Optimization and Scalability Tool–GOAST v4.0, the company said this reduces genome processing to 24 minutes, a huge improvement as researchers usually do analysis for days.
Thanks to this innovation, Lenovo said researchers, clinicians, and pharma companies can now ramp up precision medicine, cancer research, drug discovery, and national health programs.
GOAST v4.0 breaks bioinformatics bottlenecks by combining Lenovo’s HPC expertise with genomics innovation. With this leap in performance and efficiency, we are enabling real-time discoveries that can save lives and advance global health equity, said Sumir Bhatia, President, Lenovo ISG Asia Pacific.
What can the market expect from GOAST v4.0?
- Speed: Genome processing cut from 68–150 hours to just 24 minutes, a 375x improvement.
- Throughput: Up to ~22,000 genomes processed per node annually, supporting population-scale genomics.
- Affordability: GPU-level performance at significantly lower cost.
- Accessibility: Pay-as-you-go Lenovo TruScale HPC-as-a-Service, lowering barriers for labs and public health agencies.
- Sustainability: Water-cooled HPC systems reduce power consumption by up to 40 percent.
According to Lenovo, GOAST has been dominating leading institutes across the world, such as the Council of Scientific and Industrial Research – Institute of Genomics & Integrative Biology (CSIR-IGIB) and University of Delhi in India, BRIN (Indonesia), Novo Genomics (Saudi Arabia), and the Biobank of Thailand.
In the Philippine market, a medicine research institute has also started investing in GOAST.
Post a Comment